Nuvation Bio NUVB
NYSE NUVB
$5.59 -0.02 (-0.36%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nuvation Bio (NUVB) Preferred Shares (2024)

Updated

Nuvation Bio's Preferred Shares was $274.94 million in Q2 2024.

Analysis

Nuvation Bio (NUVB) Preferred Shares (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Nuvation Bio 1.94 Bn 1.94 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 274.94 Mn
API Access

Nuvation Bio Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=NUVB&period=max&api_key=YOUR_API_KEY